Beneath the Surface

A Healio podcast hosted by Joel M. Gelfand, MD, discussing the latest news and hot topics in the field of dermatology.

Beneath the Surface is a health podcast hosted by Joel M. Gelfand, MD, with 14 episodes on record and a Required Pod Score of 80.

Joel M. Gelfand, MD hosts Beneath the Surface, a health show with 14 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Beneath the Surface

  Ready for summer: Effective sunscreen use, refuting common myths

  Jul 10, 202617 min

  In this episode, guest Adewole S. Adamson, MD, MPP, discusses use of sunscreen, outlines how to decipher labels and debunks myths surrounding sunscreen. · Who should wear sunscreen, and when should they put it on? 1:16 · What ingredients should consumers look for on a sunscreen label? 5:37 · How can you differentiate between chemical and physical sunscreens? 7:27 · What are the current and upcoming innovations in sunscreens ? 8:34 · What are some myths and controversies surrounding sunscreen? 9:44 · What excites you about sunscreen now? 16:13 For more, be sure to visit the Beneath the Surface video blog on Healio.com. We'd love to hear from you! Send your comments/questions to Dr. Gelfand at podcasts@healio.com . Follow Dr. Gelfand on LinkedIn . Dr. Adamson can be reached at adewole.adamson@austin.utexas.edu or on Instagram @adeadamsonmd . Gelfand is Chief Medical Editor of Healio Dermatology. Adamson reports no relevant financial disclosures.

  ListenShow Notes
• 

  Episode #14

  Ready for summer: Effective sunscreen use, refuting common myths

  Jul 10, 202617 minS1

  In this episode, guest Adewole S. Adamson, MD, MPP, discusses use of sunscreen, outlines how to decipher labels and debunks myths surrounding sunscreen. · Who should wear sunscreen, and when should they put it on? 1:16 · What ingredients should consumers look for on a sunscreen label? 5:37 · How can you differentiate between chemical and physical sunscreens? 7:27 · What are the current and upcoming innovations in sunscreens ? 8:34 · What are some myths and controversies surrounding sunscreen? 9:44 · What excites you about sunscreen now? 16:13 For more, be sure to visit the Beneath the Surface video blog on Healio.com. We'd love to hear from you! Send your comments/questions to Dr. Gelfand at podcasts@healio.com . Follow Dr. Gelfand on LinkedIn . Dr. Adamson can be reached at adewole.adamson@austin.utexas.edu or on Instagram @adeadamsonmd . Gelfand is Chief Medical Editor of Healio Dermatology. Adamson reports no relevant financial disclosures.

  ListenShow Notes
• 

  Episode #10

  Live from AAD 2026: New treatment data for patients with PsA, obesity

  Jun 5, 20266 minS1

  In this episode, guest Joseph F. Merola, MD, discusses the results of the TOGETHER-PsA trial and explores combination therapy as an integrated approach to psoriatic arthritis (PsA) management. · What is the role of obesity in PsA? 0:55 · Dr. Merola discusses findings from the TOGETHER-PsA trial. 2:11 · Is the difference clinically meaningful to you as a rheumatologist? 4:16 · For patients today, would you combine tirzepatide with ixekizumab as a form of standard care? 5:13 Joseph Merola, MD, MMSc, is professor and chair of the department of dermatology, professor of internal medicine in the division of rheumatic diseases and professor in the UT Southwestern O'Donnell School of Public Health. We'd love to hear from you! Send your comments/questions to Dr. Gelfand at podcasts@healio.com . Follow Dr. Gelfand on LinkedIn . Dr. Merola can be reached at joseph.merola@utsouthwestern.edu . For more, be sure to visit the Beneath the Surface video blog on Healio.com. Disclosures: Eli Lilly sponsored TOGETHER-PsA. Gelfand is Chief Medical Editor of Healio Dermatology. Merola reports receiving consultant fees from AbbVie, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Eli Lilly, Incyte, Janssen, Leo Pharma, MoonLake Immunotherapeutics, Novartis, Pfizer, Sanofi-Regeneron and UCB; and grant or research support from Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Eli Lilly, Janssen, MoonLake Immunotherapeutics, Sanofi-Regeneron, Sun Pharma and UCB. References: · Merola JF, et al. Arthritis Rheumatol. 2026;doi:10.1002/art.70134. · Merola JF, et al. Late-breaking research: Session 2. Presented at: American Academy of Dermatology Annual Meeting; March 27-31, 2026; Denver.

  ListenShow Notes
• 

  Episode #12

  Diagnosing, treating complex wounds with Robert Kirsner, MD, PhD

  May 1, 202616 minS1

  In this episode, guest Robert Kirsner, MD, PhD, discusses clinical approaches to diagnosing chronic wounds, advancements and methods for treating them. · Intro 0:28 · Robert Kirsner, MD, PhD 0:35 · From a public health perspective, how big of a problem are chronic wounds? 0:59 · What is your clinical approach to define and evaluate chronic wounds? 2:06 · What imaging do you order for patients with lower extremity wounds? 4:58 · What advancements are we seeing in wound healing? 6:46 · What are some of the differential diagnoses that can generate chronic wounds in patients? 8:25 · Can you describe your technique for biopsy? 9:37 · Are there situations where you should avoid biopsy? 10:27 · Does a diagnosis of exclusion such as pyoderma gangrenosum (PG) need to be biopsied? 11:30 · Are retinoids like acitretin commonly used? 11:39 · What is your approach to patients with PG? 12:30 · Are there other immune targets that you're excited about for PG? 14:28 · Thanks for listening. 15:29 Robert Kirsner, MD, PhD, is chairman and professor in the department of dermatology and cutaneous surgery at University of Miami Miller School of Medicine, director of the University of Miami Hospital and Clinics Wound Center and a past vice president of the American Academy of Dermatology. We'd love to hear from you! Send your comments/questions to Dr. Gelfand at podcasts@healio.com . Follow Dr. Gelfand on LinkedIn . Dr. Kirsner can be reached at rkirsner@med.miami.edu . For more, be sure to visit the Beneath the Surface video blog on Healio.com. Disclosures: Gelfand is Chief Medical Editor of Healio Dermatology. Kirsner reports receiving advisory board or consultant fees from AbbVie, BPGbio, Kerecis, Leo Pharma, Organogenesis, Smith & Nephew and Urgo and grant or research support from Boehringer Ingelheim and MediWound. References: · Pyoderma gangrenosum. https://my.clevelandclinic.org/health/diseases/17825-pyoderma-gangrenosum-pg . Updated May 13, 2022. Accessed Feb. 25, 2026.

  ListenShow Notes
• 

  Episode #11

  Diagnosing, treating and managing hidradenitis suppurativa with Lauren Orenstein, MD

  Apr 3, 202628 minS1

  In this episode, guest Lauren Orenstein, MD, MSc, discusses the challenge of diagnosing hidradenitis suppurativa, the range of therapies and pain management for patients. · Intro 0:28 · Lauren Orenstein, MD, MSc 0:37 · What is HS, and how is it diagnosed? 0:57 · Is there a differential diagnosis? 2:11 · Who develops HS, and why does it develop? 3:16 · Are there biological explanations for this patient distribution in the US? 3:54 · Are there any underlying genetic or environmental factors contributing to the prevalence of HS by race in the US? 4:50 · How much of an impact do hormones have on diagnosis? 5:37 · What role does age play in diagnosis? 6:45 · Tell us about your approach to this disease. 9:30 · Are retinoids like acitretin commonly used? 11:39 · How do you choose which biologic therapy to use for management of HS? 12:25 · Are there striking differences in findings between different biologics? 14:50 · Can you explain what deroofing is and when a patient should undergo this procedure? 15:25 · How do you do this procedure clinically in your practice? 19:17 · How do you manage the pain aspect of HS? 20:31 · Do people have rebounds coming off prednisone? 23:57 · What about patients with chronic pain? 24:46 · Thanks for listening. 28:11 Lauren Orenstein, MD, MSc, is an assistant professor in the department of dermatology at Emory University and staff physician at Grady Memorial Hospital. We'd love to hear from you! Send your comments/questions to Dr. Gelfand at podcasts@healio.com . Follow Dr. Gelfand on LinkedIn . Dr. Orenstein can be reached at lauren.orenstein@emory.edu . For more, be sure to visit the Beneath the Surface video blog on Healio.com. Disclosures: Gelfand is Chief Medical Editor of Healio Dermatology. Orenstein reports financial relationships with Incyte, Novartis, Pfizer and UCB Pharma and is a member of the board of directors for the HS Foundation.

  ListenShow Notes

Recent guests on Beneath the Surface. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.